Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amrize (AMRZ) Liabilities and Shareholders Equity (2024 - 2025)

Amrize (AMRZ) has disclosed Liabilities and Shareholders Equity for 2 consecutive years, with $24.2 billion as the latest value for Q4 2025.

  • Quarterly Liabilities and Shareholders Equity rose 1.87% to $24.2 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $95.9 billion through Dec 2025, changed N/A year-over-year, with the annual reading at $24.2 billion for FY2025, 1.87% up from the prior year.
  • Liabilities and Shareholders Equity hit $24.2 billion in Q4 2025 for Amrize, up from $24.0 billion in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $24.2 billion in Q4 2025 to a low of $23.8 billion in Q2 2025.